Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
CompletedOBSERVATIONAL
Enrollment
1,536
Participants
Timeline
Start Date
January 31, 2006
Primary Completion Date
October 31, 2006
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG
Tiotropium bromide
Tiotropium bromide18 micrograms by oral inhalation (1 x daily) with the HandiHaler®
NCT02172521 - Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation | Biotech Hunter | Biotech Hunter